Stoke Therapeutics Inc. (STOK)

AI Score

Unlock

7.69

0.13 (1.72%)

At close: Apr 17, 2025, 3:59 PM

7.68

-0.15%

After-hours: Apr 17, 2025, 05:42 PM EDT

Dividends

No dividend history available for Stoke Therapeutics Inc..

Pro Subscription

Upgrade now for unlimited access to all data and tools.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Related Stocks

Company	Dividend Yield

Dividend Rankings

STOK News

2 weeks ago · Stoke Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference - businesswire.com
1 month ago · Stoke Therapeutics Stock Slips as CEO Steps Down - investopedia.com
1 month ago · Stoke Therapeutics, Inc. (STOK) Reports Q4 Loss, Tops Revenue Estimates - zacks.com
1 month ago · Stoke Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates - businesswire.com
1 month ago · Stoke Therapeutics Announces CEO Transition - businesswire.com
1 month ago · Stoke Therapeutics, Inc. (STOK) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - zacks.com
1 month ago · Stoke Therapeutics to Present at Upcoming Investor Conferences in March - businesswire.com
1 month ago · Biogen and Stoke Therapeutics Enter into Collaboration to Develop and Commercialize Zorevunersen for the Treatment of Dravet Syndrome, a Rare Genetic Epilepsy Associated with Refractory Seizures and Neurodevelopmental Impairments - businesswire.com
2 months ago · Stoke Therapeutics: A Pivotal Moment For This RNA Pioneer - seekingalpha.com
2 months ago · Strength Seen in Stoke Therapeutics (STOK): Can Its 9.4% Jump Turn into More Strength? - zacks.com